Differential Expression of Plasma Metabolites in Patients with Pulmonary Sarcoidosis is Associated with Clinical Behavior

D. Kass, S. Strock, M. Nouraie, J. Chiarchiaro, K. Veraldi, Yingze Zhang, K. Gibson
{"title":"Differential Expression of Plasma Metabolites in Patients with Pulmonary Sarcoidosis is Associated with Clinical Behavior","authors":"D. Kass, S. Strock, M. Nouraie, J. Chiarchiaro, K. Veraldi, Yingze Zhang, K. Gibson","doi":"10.1183/13993003.CONGRESS-2018.PA5215","DOIUrl":null,"url":null,"abstract":"Introduction: We hypothesized that a comprehensive metabolomic analysis of plasma from sarcoid patients (pts) would identify potential biomarkers of disease severity. Methods & Results: This study is a cross-sectional analysis of sarcoid pts seen at our Center between February 2003 and July 2014. Plasma from 60 pulmonary sarcoid patients and 40 aged-matched donor controls were tested (Table 1) was subjected to metabolomic profiling (Metabolon) for 893 known biochemicals. Following normalization to volume extracted, log transformation and imputation of missing values, if any, with the minimum observed value for each compound, ANOVA contrasts and Welch’s two-sample t-test were used to identify biochemicals that differed significantly between experimental groups. Differential expression of chemicals that were decreased in sarcoid included steroids, but notably not prednisone, which is consistent with steroid treatment and adrenal suppression. Differential expression of chemicals that were increased in sarcoid mapped to amino acid metabolism. In sarcoid pts only, based on Pearson correlations, one amino acid, N-acetylthreonine, was associated with FVC (R=−0.38, P Conclusion: Metabolomics profiling for biomarker discovery in sarcoid is feasible, and candidate biomarkers should be prioritized for further testing.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"82 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sarcoidosis and other granulomatous ILD/DPLD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA5215","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: We hypothesized that a comprehensive metabolomic analysis of plasma from sarcoid patients (pts) would identify potential biomarkers of disease severity. Methods & Results: This study is a cross-sectional analysis of sarcoid pts seen at our Center between February 2003 and July 2014. Plasma from 60 pulmonary sarcoid patients and 40 aged-matched donor controls were tested (Table 1) was subjected to metabolomic profiling (Metabolon) for 893 known biochemicals. Following normalization to volume extracted, log transformation and imputation of missing values, if any, with the minimum observed value for each compound, ANOVA contrasts and Welch’s two-sample t-test were used to identify biochemicals that differed significantly between experimental groups. Differential expression of chemicals that were decreased in sarcoid included steroids, but notably not prednisone, which is consistent with steroid treatment and adrenal suppression. Differential expression of chemicals that were increased in sarcoid mapped to amino acid metabolism. In sarcoid pts only, based on Pearson correlations, one amino acid, N-acetylthreonine, was associated with FVC (R=−0.38, P Conclusion: Metabolomics profiling for biomarker discovery in sarcoid is feasible, and candidate biomarkers should be prioritized for further testing.
肺结节病患者血浆代谢物的差异表达与临床行为的关系
我们假设对肉瘤患者的血浆进行全面的代谢组学分析将识别疾病严重程度的潜在生物标志物。方法与结果:本研究是对2003年2月至2014年7月在我中心所见的结节样病变进行横断面分析。对60名肺肉瘤患者和40名年龄匹配的供体对照进行了血浆测试(表1),对893种已知生化物质进行了代谢组学分析(Metabolon)。在对提取的体积进行归一化、对数变换和缺失值(如果有的话)与每种化合物的最小观察值进行归一化后,使用方差分析对比和韦尔奇的双样本t检验来识别实验组之间存在显著差异的生化物质。肉瘤中化学物质的差异表达减少包括类固醇,但明显没有强的松,这与类固醇治疗和肾上腺抑制一致。在肉瘤中增加的化学物质的差异表达与氨基酸代谢有关。仅在肉瘤患者中,基于Pearson相关性,一种氨基酸n -乙酰苏氨酸与FVC相关(R= - 0.38, P)。结论:代谢组学分析在肉瘤患者中发现生物标志物是可行的,应优先选择候选生物标志物进行进一步检测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书